E-LIB Suche - Ergebnisse für: Garrelfs, Sander

1

#5635 SYSTEMIC OXALOSIS: AN OVERVIEW OF THE FINDINGS AND PR..:

Deesker, Lisa ; Garrelfs, Sander ; Groothoff, Jaap
Nephrology Dialysis Transplantation. 38 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

2

Clinical practice recommendations for primary hyperoxaluria..:

Groothoff, Jaap W. ; Metry, Ella ; Deesker, Lisa...
Nature Reviews Nephrology. 19 (2023) 3 - p. 194-211 , 2023

Link: https://doi.org/10.1038/..

3

Genetic assessment in primary hyperoxaluria: why it matters:

Mandrile, Giorgia ; Beck, Bodo ; Acquaviva, Cecile...
Pediatric Nephrology. 38 (2022) 3 - p. 625-634 , 2022

Link: https://doi.org/10.1007/..

4

MO047STABLE EGFR IN PATIENTS WITH PRIMARY HYPEROXALURIA TYP..:

Hayes, Wesley ; Garrelfs, Sander ; Sas, David...
Nephrology Dialysis Transplantation. 36 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

5

MO436PLASMA OXALATE VALUES IN PATIENTS WITH END-STAGE KIDNE..:

Metry, Ella ; Garrelfs, Sander ; Oosterveld, Michiel...
Nephrology Dialysis Transplantation. 36 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

6

FC 013LUMASIRAN DEMONSTRATED COMPARABLE OXALATE REDUCTION A..:

Shasha-Lavsky, Hadas ; Garrelfs, Sander ; Sas, David...
Nephrology Dialysis Transplantation. 36 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

7

LB002ILLUMINATE-A, A PHASE 3 STUDY OF LUMASIRAN, AN INVESTI..:

Lieske, John ; McGregor, Tracy ; Gansner, John...
Nephrology Dialysis Transplantation. 35 (2020) Supplement_3 - p. , 2020

Link: https://doi.org/10.1093/..

8

Glyoxylate reductase: Definitive identification in human li..:

Garrelfs, Sander F. ; Chornyi, Serhii ; te Brinke, Heleen...
Journal of Inherited Metabolic Disease. 47 (2024) 2 - p. 280-288 , 2024

Link: https://doi.org/10.1002/..

9

Determinants of Kidney Failure in Primary Hyperoxaluria Typ..:

Metry, Elisabeth L. ; Garrelfs, Sander F. ; Deesker, Lisa J....
Kidney International Reports. 8 (2023) 10 - p. 2029-2042 , 2023

Link: https://doi.org/10.1016/..

10

Plasma oxalate and glycolate concentrations in dialysis pat..:

Metry, Elisabeth L ; Garrelfs, Sander F ; Peters-Sengers, Hessel...
Nephrology Dialysis Transplantation. 38 (2023) 7 - p. 1773-1775 , 2023

Link: https://doi.org/10.1093/..

11

Glycolate oxidase inhibition by lumasiran varies between pa..:

Garrelfs, Sander F. ; Metry, Elisabeth L. ; van Harskamp, Dewi...
Kidney International. 103 (2023) 5 - p. 990-993 , 2023

Link: https://doi.org/10.1016/..

12

Safety, pharmacodynamics, and exposure-response modeling re..:

Hoppe, Bernd ; Koch, Annelize ; Cochat, Pierre...
Kidney International. 101 (2022) 3 - p. 626-634 , 2022

Link: https://doi.org/10.1016/..

13

Primary hyperoxaluria: the pediatric nephrologist's point o..:

Ben-Shalom, Efrat ; Garrelfs, Sander F ; Groothoff, Jaap W
Clinical Kidney Journal. 15 (2022) Supplement_1 - p. i23-i28 , 2022

Link: https://doi.org/10.1093/..

14

The retinal phenotype in primary hyperoxaluria type 2 and 3:

Birtel, Johannes ; Diederen, Roselie M. ; Herrmann, Philipp...
Pediatric Nephrology. 38 (2022) 5 - p. 1485-1490 , 2022

Link: https://doi.org/10.1007/..

15

Improved Outcome of Infantile Oxalosis Over Time in Europe:..:

Deesker, Lisa J. ; Garrelfs, Sander F. ; Mandrile, Giorgia...
Kidney International Reports. 7 (2022) 7 - p. 1608-1618 , 2022

Link: https://doi.org/10.1016/..